Evidence map›Paper›PMID 30769824›Full record

ArticleViruses2019

The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity.

Ge Li, Sandra Bos, Konstantin A Tsetsarkin, Alexander G Pletnev, Philippe Desprès, Gilles Gadea, Richard Y Zhao

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. An overview of Zika virus genotypes and their infectivity.Revista da Sociedade Brasileira de Medicina Tropical · 2022
    Review
  13. Leu-to-Phe substitution at prMScientific reports · 2021
    Article
  14. Article
  15. Article
  16. The Dual Regulation of Apoptosis by Flavivirus.Frontiers in microbiology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ge LiDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. lige_cn@hotmail.com.
Sandra BosUnité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de La Réunion, INSERM U1187, CNRS UMR 9192, IRD UMR 249, Sainte-Clotilde, 97400 La Réunion, France. SandraBos.Lab@gmail.com.ORCID 0000-0001-5036-0336
Konstantin A TsetsarkinLaboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA. konstantin.tsetsarkin@nih.gov.
Alexander G PletnevLaboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA. apletnev@niaid.nih.gov.
Philippe DesprèsUnité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de La Réunion, INSERM U1187, CNRS UMR 9192, IRD UMR 249, Sainte-Clotilde, 97400 La Réunion, France. philippe.despres@univ-reunion.fr.ORCID 0000-0001-8926-4050
Gilles GadeaUnité Mixte Processus Infectieux en Milieu Insulaire Tropical, Plateforme Technologique CYROI, Université de La Réunion, INSERM U1187, CNRS UMR 9192, IRD UMR 249, Sainte-Clotilde, 97400 La Réunion, France. gilles.gadea@inserm.fr.ORCID 0000-0001-6325-4866
Richard Y ZhaoDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. rzhao@som.umaryland.edu.
Centre National de la Recherche Scientifique · FRNational Institutes of Health · USUniversity of Maryland, Baltimore · US

Funding

Development Of New Approaches To Vaccines Against TBEV and West Nile VirusZIAAI000637 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PLETNEV, ALEXANDER · 2009 to 2022
$19.1M
Rapid Phenotyping of the ZIKV GenomeR21AI129369 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ZHAO, RICHARD YUQI · 2017 to 2018
$425k
NIAID NIH HHS R21 AI129369
6 · The paper itself

Abstract

The Zika virus (ZIKV) was first isolated in Africa in 1947. It was shown to be a mild virus that had limited threat to humans. However, the resurgence of the ZIKV in the most recent Brazil outbreak surprised us because it causes severe human congenital and neurologic disorders including microcephaly in newborns and Guillain-Barré syndrome in adults. Studies showed that the epidemic ZIKV strains are phenotypically different from the historic strains, suggesting that the epidemic ZIKV has acquired mutations associated with the altered viral pathogenicity. However, what genetic changes are responsible for the changed viral pathogenicity remains largely unknown. One of our early studies suggested that the ZIKV structural proteins contribute in part to the observed virologic differences. The objectives of this study were to compare the historic African MR766 ZIKV strain with two epidemic Brazilian strains (BR15 and ICD) for their abilities to initiate viral infection and to confer neurocytopathic effects in the human brain's SNB-19 glial cells, and further to determine which part of the ZIKV structural proteins are responsible for the observed differences. Our results show that the historic African (MR766) and epidemic Brazilian (BR15 and ICD) ZIKV strains are different in viral attachment to host neuronal cells, viral permissiveness and replication, as well as in the induction of cytopathic effects. The analysis of chimeric viruses, generated between the MR766 and BR15 molecular clones, suggests that the ZIKV E protein correlates with the viral attachment, and the C-prM region contributes to the permissiveness and ZIKV-induced cytopathic effects. The expression of adenoviruses, expressing prM and its processed protein products, shows that the prM protein and its cleaved Pr product, but not the mature M protein, induces apoptotic cell death in the SNB-19 cells. We found that the Pr region, which resides on the N-terminal side of prM protein, is responsible for prM-induced apoptotic cell death. Mutational analysis further identified four amino-acid residues that have an impact on the ability of prM to induce apoptosis. Together, the results of this study show that the difference of ZIKV-mediated viral pathogenicity, between the historic and epidemic strains, contributed in part the functions of the structural prM-E proteins.

Indexed as

Virus AttachmentAfricaApoptosisBrainBrazilDisease OutbreaksEpidemicsHumansMutationNeurogliaViral Envelope ProteinsVirus ReplicationZika VirusZika Virus InfectionprM protein, FlavivirusViral Envelope Proteinsapoptosischimeric virusescytopathic effectshuman brain glial cellsmutagenesisprM-E proteinsviral pathogenicityviral permissivenessviral replicationviral survivalvirus attachmentZika virus

Identifiers

PMID30769824
PMCPMC6409645
OpenAlexW2914815751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.